Literature DB >> 10956663

Spatial regulation and activity modulation of plasmin by high affinity binding to the G domain of the alpha 3 subunit of laminin-5.

L E Goldfinger1, L Jiang, S B Hopkinson, M S Stack, J C Jones.   

Abstract

Cells in complex tissues contact extracellular matrix that interacts with integrin receptors to influence gene expression, proliferation, apoptosis, adhesion, and motility. During development, tissue remodeling, and tumorigenesis, matrix components are modified by enzymatic digestion with subsequent effects on integrin binding and signaling. We are interested in understanding the mechanisms by which broad spectrum proteinases such as plasmin are targeted to their extracellular matrix protein substrates. We have utilized plasmin-mediated cleavage of the epithelial basement membrane glycoprotein laminin-5 as a model to evaluate molecular events that direct plasmin activity to specific structural domains. We report that plasminogen and tissue plasminogen activator (tPA) exhibit high affinity, specific binding to the G(1) subdomain of the N terminus of the laminin-5 alpha(3) subunit, with equilibrium dissociation constants of 50 nm for plasminogen and 80 nm for tPA. No high affinity binding to the G(2), G(3), and G(4) subdomains was observed. As a result of binding to the G(1) subdomain, the catalytic efficiency of tPA-catalyzed plasminogen activation is enhanced 32-fold, leading to increased matrix-associated plasmin that is positioned favorably for cleavage within the G(4) subdomain as we have reported previously (Goldfinger, L. E., Stack, M. S., and Jones, J. C. R. (1998) J. Cell Biol. 141, 255-265). Thus, physical constraints dictated by interaction of proteinase and matrix macromolecule control not only enzymatic activity but may regulate substrate targeting of proteinases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10956663     DOI: 10.1074/jbc.M006652200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Novel and recurrent mutations in the laminin-5 genes causing lethal junctional epidermolysis bullosa: molecular basis and clinical course of Herlitz disease.

Authors:  Christiane Mühle; Qiu-Jie Jiang; Alexandra Charlesworth; Leena Bruckner-Tuderman; Guerrino Meneguzzi; Holm Schneider
Journal:  Hum Genet       Date:  2004-11-05       Impact factor: 4.132

Review 2.  Laminin-332-integrin interaction: a target for cancer therapy?

Authors:  Daisuke Tsuruta; Hiromi Kobayashi; Hisayoshi Imanishi; Koji Sugawara; Masamitsu Ishii; Jonathan C R Jones
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

3.  Substrate stiffness regulates extracellular matrix deposition by alveolar epithelial cells.

Authors:  Jessica L Eisenberg; Asmahan Safi; Xiaoding Wei; Horacio D Espinosa; Gr Scott Budinger; Desire Takawira; Susan B Hopkinson; Jonathan Cr Jones
Journal:  Res Rep Biol       Date:  2011-01

4.  Plasminogen enhances neuritogenesis on laminin-1.

Authors:  Ana Gutiérrez-Fernández; Neill A Gingles; Hongdong Bai; Francis J Castellino; Robert J Parmer; Lindsey A Miles
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

5.  Chain-specific heparin-binding sequences in the laminin alpha chain LG45 modules.

Authors:  Kentaro Hozumi; Nobuharu Suzuki; Yoshihiko Uchiyama; Fumihiko Katagiri; Yamato Kikkawa; Motoyoshi Nomizu
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

6.  The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release.

Authors:  Taku Nagai; Kiyofumi Yamada; Masako Yoshimura; Kazuhiro Ishikawa; Yoshiaki Miyamoto; Kazuki Hashimoto; Yukihiro Noda; Atsumi Nitta; Toshitaka Nabeshima
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

7.  Autocrine transforming growth factor-{beta}1 activation mediated by integrin {alpha}V{beta}3 regulates transcriptional expression of laminin-332 in Madin-Darby canine kidney epithelial cells.

Authors:  Jose V Moyano; Patricia G Greciano; Mary M Buschmann; Manuel Koch; Karl S Matlin
Journal:  Mol Biol Cell       Date:  2010-09-15       Impact factor: 4.138

8.  Biological network inferences for a protection mechanism against familial Creutzfeldt-Jakob disease with E200K pathogenic mutation.

Authors:  Sol Moe Lee; Myungguen Chung; Kyu Jam Hwang; Young Ran Ju; Jae Wook Hyeon; Jun-Sun Park; Chi-Kyeong Kim; Sangho Choi; Jeongmin Lee; Su Yeon Kim
Journal:  BMC Med Genomics       Date:  2014-08-22       Impact factor: 3.063

Review 9.  Cell surface remodeling by plasmin: a new function for an old enzyme.

Authors:  Elena I Deryugina; James P Quigley
Journal:  J Biomed Biotechnol       Date:  2012-10-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.